BioSpace News Archive

DRE Health Corporation announced their plans to build a manufacturing plant for disposable face masks in the United States in response to the recent global Coronavirus outbreak.

Kewaunee Scientific Corporation reported results for its third quarter of fiscal year 2020, ended January 31, 2020.

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that the company will present an abstract in a poster session at the upcoming AACR Annual Meeting, which is being held April 24 – 29, 2020 at the San Diego Convention Center.

Enabling Low-Cost, High-Volume Sequencing of Drug-Resistant Pathogens for Hospital Infection Control and Surveillance

Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), today announced that the results from its pivotal cellulite trial have been accepted for oral presentation at the American Academy of Dermatology (AAD) 2020 Annual Meeting, being held March 20-24 in Denver, CO.

MAX BioPharma, Inc. (www.maxbiopharma.com) recently published an article describing its anti-tumorigenic oxysterol lead compound, Oxy210, in the peer-reviewed journal, Cells. (https://www.mdpi.com/2073-4409/8/10/1297/pdf).

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers, today announced it will release its fourth quarter and full year 2019 financial results before the market opens on Thursday, March 12, 2020

BioIVT’s acquisition of Clinical Trial Laboratory Services (CTLS) and its London donor center is enabling this rapid turnaround time for high quality blood-derived immune cells for cell and gene therapy research

Company also exhibiting cloud-based transportation coordination platform at RISE Medicare Advantage Summit and AMGA Annual Conference

GALE|QKIT allows municipalities and governments to safely monitor patients’ health at home using smart diagnostic devices, maximizing the period during which individuals being evaluated for possible infection can remain at home